Search research articles
Contact Us
Filters
Showing results (21-30 of 120) with videos related to
Page
of 12
Sort By:
Digestive Diseases and Sciences
|
March 28, 2016
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
Dharmesh H Kaswala, Michelle Lai, Nezam H Afdhal
Gastroenterology & Hepatology
|
May 5, 2012
Chronic hepatitis B: integrating long-term treatment data and strategies to improve outcomes in clinical practice
Nezam H Afdhal, Bruce R Bacon, Robert S Brown
Transplantation
|
April 25, 2017
Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C
Elliot B Tapper, Nezam H Afdhal, Michael P Curry
Journal of Lipid Research
|
December 29, 2005
Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice
Helen H Wang, Nezam H Afdhal, David Q-H Wang
Gastroenterology
|
July 6, 2004
Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones
Helen H Wang, Nezam H Afdhal, David Q-H Wang
Journal of Hepatology
|
November 18, 2008
Exceeding the limits of liver histology markers
Shruti H Mehta, Bryan Lau, Nezam H Afdhal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 12, 2005
Management of hepatitis C virus in special populations: patient and treatment considerations
Robert G Gish, Nezam H Afdhal, Douglas T Dieterich, et al.
The American Journal of Gastroenterology
|
May 25, 2007
The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver
Valerie Byrnes, Hongyu Shi, Shigeru Kiryu, et al.
Journal of Clinical Gastroenterology
|
February 1, 2011
Circulating microRNAs as biomarkers for hepatocellular carcinoma
Kevin Z Qu, Ke Zhang, HaiRong Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 14, 2010
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis
Detlef Schuppan, Mark D Gorrell, Thomas Klein, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 120) with videos related to
Sort By:
Page
of 12
Digestive Diseases and Sciences
|
March 28, 2016
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
Dharmesh H Kaswala, Michelle Lai, Nezam H Afdhal
Gastroenterology & Hepatology
|
May 5, 2012
Chronic hepatitis B: integrating long-term treatment data and strategies to improve outcomes in clinical practice
Nezam H Afdhal, Bruce R Bacon, Robert S Brown
Transplantation
|
April 25, 2017
Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C
Elliot B Tapper, Nezam H Afdhal, Michael P Curry
Journal of Lipid Research
|
December 29, 2005
Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice
Helen H Wang, Nezam H Afdhal, David Q-H Wang
Gastroenterology
|
July 6, 2004
Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones
Helen H Wang, Nezam H Afdhal, David Q-H Wang
Journal of Hepatology
|
November 18, 2008
Exceeding the limits of liver histology markers
Shruti H Mehta, Bryan Lau, Nezam H Afdhal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 12, 2005
Management of hepatitis C virus in special populations: patient and treatment considerations
Robert G Gish, Nezam H Afdhal, Douglas T Dieterich, et al.
The American Journal of Gastroenterology
|
May 25, 2007
The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver
Valerie Byrnes, Hongyu Shi, Shigeru Kiryu, et al.
Journal of Clinical Gastroenterology
|
February 1, 2011
Circulating microRNAs as biomarkers for hepatocellular carcinoma
Kevin Z Qu, Ke Zhang, HaiRong Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 14, 2010
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis
Detlef Schuppan, Mark D Gorrell, Thomas Klein, et al.
Page
of 12